Back
Astronics Corp. 10K Form
Sell
31
ATROB
Astronics Corp.
Last Price:
$61.90
Seasonality Move:
9.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-10-30 | 10Q | ATROB/Astronics Corp. Quarterly |
| 2020-08-04 | 10Q | ATROB/Astronics Corp. Quarterly |
| 2020-05-07 | 10Q | ATROB/Astronics Corp. Quarterly |
| 2020-03-02 | 10K | ATROB/Astronics Corp. Annual |
| 2019-11-07 | 10Q | ATROB/Astronics Corp. Quarterly |
| 2019-08-08 | 10Q | ATROB/Astronics Corp. Quarterly |
Receive ATROB News And Ratings
See the #1 stock for the next 7 days that we like better than ATROB
ATROB Financial Statistics
Sales & Book Value
| Annual Sales: | $862.1M |
|---|---|
| Cash Flow: | $23.9M |
| Price / Cash Flow: | 54.99 |
| Annual Sales: | $4.25 |
| Price / Book: | 15.77 |
Profitability
| EPS (TTM): | 0.72350 |
|---|---|
| Net Income (TTM): | $29.4M |
| Gross Margin: | $258.2M |
| Return on Equity: | 14.07% |
| Return on Assets: | 4.35% |
Astronics Corp. Earnings Forecast
Key Astronics Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for ATROB is 29.94%.
-
The Selling, General & Administrative Expenses for ATROB have been equal to 16.04% of Gross Profit Margin.
-
The Research & Development expenses have been 5.04% of Revenue.
-
The Interest Expense is 42.78% of Operating Income.
-
The Net Earning history of ATROB is 3.41% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 19 years.
Astronics Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Aerospace & Defense |
| Sector: | Industrials |
| Current Symbol: | ATROB |
| Website: | astronics.com |
Debt
| Debt-to-Equity Ratio: | 2.7 |
|---|---|
| Current Ratio: | 3.1 |
| Quick Ratio: | 1.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 76.88 |
|---|---|
| Forward P/E Ratio: | 0 |
ATROB Technical Analysis vs Fundamental Analysis
Sell
31
Astronics Corp. (ATROB)
is a Sell
Is Astronics Corp. a Buy or a Sell?
-
Astronics Corp. stock is rated a SellThe current Astronics Corp. [ATROB] share price is $61.90. The Score for ATROB is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.